ISSN: 2278-0238

薬学および生命科学における研究開発の国際ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

ENHANCEMENT OF SOLUBILITY OF POORLY WATER SOLUBLE DRUGS DICLOFENAC SODIUM BY MIXED SOLVENCY APPROACH

Masheer Ahmed Khan

Enhancement of solubility is one of the difficult tasks which become challenges in formulation development of orally administered drug with poor aqueous solubility. Poor water solubility of drugs often causes significant problems in producing formulations of sufficiently high bioavailability, preventing effective use of the drugs. 'Mixed-solvency ' concept is the phenomenon to increase the solubility of poorly water-soluble drugs in the aqueous solution containing blends of hydrotropic agents, co-solvents and water soluble solutes which may give synergistic enhancement effect on solubility of such drugs. In the present investigation , mixed solvency approach has been applied for the enhancement of aqueous solubility of a poorly water- soluble drugs diclofenec sodium (selected as a model drug), by making blends of randomly selected water-soluble substances from among the hydrotropic (urea, sodium acetate); water soluble solutes (PEG4000, PEG6000); and co-solvents (PEG200, PEG400). The aqueous solubility of diclofenac sodium was observed at room temperature in the randomly selected blends of solubilizers containing different combinations keeping total concentration 50%w/v constant. Diclofenec sodium have λmax 276 nm and obeys Beers Law in concentration range of 10-60 μg/ml. The results suggest that solubility of the diclofenac sodium containing blends of varying combinations was enhanced significantly using mixed solvency approach.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。